Drug LitigationPradaxa: A Billion Dollar Drug

November 25, 2012

Pradaxa, a popular and powerful blood thinner, earned more than $1 billion in revenue in 2011. Although many patients happily used the drug without consequence, thousands of consumers experienced an adverse event, according to the Food and Drug Administration (FDA). More than 500 people died as a result of this drug alone.

 

The maker of Pradaxa spent almost half a billion in marketing, attempting to convince consumers that their drug was worth the risk. However, some patients feel that the risks were understated, particularly considering that health care professionals such as the highly respected Cleveland Clinic have noted that Pradaxa patients’ risk of heart attack and bleeding complications rise as a result of Pradaxa ingredients.

 

Did the maker of Pradaxa violate your rights with their product marketing? It’s an important question to ask. It’s an even more important question to answer. The attorneys at the law firm of Nachawati Law Group know how to advise you of your rights. With years of experience and dedicated expertise, we’re ready to fight for you. We can help you.

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy